[1]
E. Kolanchinathan, D. T. Harichandran, S. M. Balakrishnan, and S. K. K. Balakumaran, “Adverse drug reactions to first line anti-tuberculosis drugs in newly diagnosed tuberculosis patients”, Int J Basic Clin Pharmacol, vol. 11, no. 1, pp. 65–69, Dec. 2021.